Australia markets closed

Aroa Biosurgery Limited (ARX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.1500-0.0350 (-2.95%)
At close: 4:10PM AEST
Currency in AUD

Valuation measures

Market cap (intra-day) 5345.09M
Enterprise value 3320.96M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)16.36
Price/book (mrq)5.53
Enterprise value/revenue 315.22
Enterprise value/EBITDA 7-50.18

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-14.81%
S&P500 52-week change 349.51%
52-week high 31.7450
52-week low 30.9700
50-day moving average 31.1867
200-day moving average 31.2210

Share statistics

Avg vol (3-month) 3296.11k
Avg vol (10-day) 3139.9k
Shares outstanding 5300.08M
Implied shares outstanding 6300.73M
Float 192.52M
% held by insiders 139.59%
% held by institutions 110.06%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in NZD.

Fiscal year

Fiscal year ends 31 Mar 2020
Most-recent quarter (mrq)30 Sep 2020


Profit margin -88.07%
Operating margin (ttm)-41.46%

Management effectiveness

Return on assets (ttm)N/A
Return on equity (ttm)N/A

Income statement

Revenue (ttm)21.09M
Revenue per share (ttm)0.36
Quarterly revenue growth (yoy)-30.30%
Gross profit (ttm)18.74M
Net income avi to common (ttm)-18.57M
Diluted EPS (ttm)-0.2910
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)40.54M
Total cash per share (mrq)0.14
Total debt (mrq)16.42M
Total debt/equity (mrq)26.34
Current ratio (mrq)12.48
Book value per share (mrq)0.21

Cash flow statement

Operating cash flow (ttm)-4.07M
Levered free cash flow (ttm)N/A